Does a simple hematological examination predict the response and side effects in patients undergoing induction chemotherapy and/or neoadjuvant chemotherapy?
J Chin Med Assoc
.
2020 Feb;83(2):107-108.
doi: 10.1097/JCMA.0000000000000239.
Authors
Wen-Ling Lee
1
2
,
I-San Chan
3
4
,
Peng-Hui Wang
3
4
5
6
Affiliations
1
Department of Medicine, Cheng-Hsin General Hospital, Taipei, Taiwan, ROC.
2
Department of Nursing, Oriental Institute of Technology, New Taipei City, Taiwan, ROC.
3
Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
4
Department of Obstetrics and Gynecology, National Yang-Ming University, Taipei, Taiwan, ROC.
5
Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.
6
Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, ROC.
PMID:
31868856
DOI:
10.1097/JCMA.0000000000000239
No abstract available
Publication types
Editorial
Comment
MeSH terms
Chemotherapy, Adjuvant
Docetaxel
Head and Neck Neoplasms*
Humans
Induction Chemotherapy
Lymphocytes
Neoadjuvant Therapy*
Neutrophils
Substances
Docetaxel